Original explanatory diagram
FDA’s January AI-device lifecycle draft asked sponsors for an evidence trail, while remaining nonbinding and open for comment
FDA’s January 7, 2025 draft proposed lifecycle and submission documentation for AI-enabled devices, but it was nonbinding draft guidance rather than a new enforceable rule.
Read analysis
